Abstract
The nonadherent (NA) population of bone-marrow-derived mononuclear cells (MNC) has been demonstrated to be a source of osteogenic precursors in addition to the plastic-adherent mesenchymal stromal cells (MSC). In the current study, two subpopulations of late adherent (LA) osteoprogenitors were obtained by subsequent replating of NA cells, and their phenotypic, functional, and molecular properties were compared with those of early adherent (EA) MSC. Approximately 35% of MNC were LA cells, and they acquired a homogeneous expression of MSC antigens later than EA cells. In EA-MSC, the alkaline phosphatase (ALP) activity increased significantly from time of seeding to the first confluence, whereas in LA cells it raised later, after the addition of mineralization medium. All subpopulations were able to produce type I collagen and to deposit extracellular matrix with organized collagen fibrils. The proportion of large colonies with more than 50% of ALP positive cells as well as the calcium content was higher in LA than in EA cells. Molecular analysis highlighted the upregulation of bone-related genes in LA-MSC, especially after the addition of mineralization medium. Our results confirm that bone marrow contains LA osteoprogenitors which exhibit a delay in the differentiation process, despite an osteogenic potential similar to or better than EA-MSC. LA cells represent a reservoir of osteoprogenitors to be recruited to gain an adequate bone tissue repair and regeneration when a depletion of the most differentiated component occurs. Bone tissue engineering and cell therapy strategies could take advantage of LA cells, since an adequate amount of osteogenic MSCs may be obtained while avoiding bone marrow manipulation and cell culture expansion.






References
Baksh D, Song L, Tuan RS (2004) Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8:301–316
Bianco P, Riminucci M, Gronthos S, Robey PG (2001) Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19:180–192
Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G (1998) Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 23:187–196
Brooke G, Cook M, Blair C, Han R, Heazlewood C, Jones B, Kambouris M, Kollar K, McTaggart S, Pelekanos R, Rice A, Rossetti T, Atkinson K (2007) Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol 18:846–858
Ciapetti G, Ambrosio L, Marletta G, Baldini N, Giunti A (2006) Human bone marrow stromal cells: in vitro expansion and differentiation for bone engineering. Biomaterials 27:6150–6160
Dallari D, Savarino L, Stagni C, Cenni E, Cenacchi A, Fornasari PM, Albisinni U, Rimondi E, Baldini N, Giunti A (2007) Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow and stromal cells. J Bone Joint Surg Am 89:2413–2420
Di Cesare PE, Fang C, Leslie MP, Tulli H, Perris R, Carlson CS (2000) Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts. J Orthop Res 18:713–720
Dominici M, Pritchard C, Garlits JE, Hofmann TJ, Persons DA, Horwitz EM (2004) Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci USA 101:11761–11766
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy 8:315–317
Eghbali-Fatourechi GZ, Modder UI, Charatcharoenwitthaya N, Sanyal A, Undale AH, Clowes JA, Tarara JE, Khosla S (2007) Characterization of circulating osteoblast lineage cells in humans. Bone 40:1370–1377
Eipers PG, Kale S, Taichman RS, Pipia GG, Swords NA, Mann KG, Long MW (2000) Bone marrow accessory cells regulate human bone precursor cell development. Exp Hematol 28:815–825
Falla N, Van Vlasselaer P, Bierkens J, Borremans B, Schoeters G, Van Gorp U (1993) Characterization of a 5-fluorouracil-enriched osteoprogenitor population of the murine bone marrow. Blood 82:3580–3591
Gori F, Hofbauer LC, Dunstan CR, Spelsberg TC, Khosla S, Riggs BL (2000) The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal–osteoblast lineage cells is developmentally regulated. Endocrinology 41:4768–4776
Granero-Molto F, Weis JA, Longobardi L, Spagnoli A (2008) Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair. Expert Opin Biol Ther 8(3):255–268
Hernigou P, Mathieu G, Poignard A, Manicom O, Beaujean F, Rouard H (2006) Percutaneous autologous bone-marrow grafting for nonunions: surgical technique. J Bone Joint Surg Am 88(S1):322–327
Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A (2005) The International Society for Cellular Therapy Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7:393–395
Huang W, Yang S, Shao J, Li YP (2007) Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci 12:3068–3092
Iba K, Chiba H, Yamashita T, Ishii S, Sawada N (2001) Phase-independent inhibition by retinoic acid of mineralization correlated with loss of tetranectin expression in a human osteoblastic cell line. Cell Struct Funct 26:227–233
Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, Tukun A, Uckan D, Can A (2007) Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 25:319–331
Katoh M (2008) WNT signaling in stem cell biology and regenerative medicine. Curr Drug Targets 9:565–570
Kumagai K, Vasanji A, Drazba JA, Butler RS, Muschler GF (2008) Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res 26(2):165–175
Litvin J, Selim AH, Montgomery MO, Lehmann K, Rico MC, Devlin H, Bednarik DP, Safadi FF (2004) Expression and function of periostin-isoforms in bone. J Cell Biochem 92:1044–1061
Long MW, Williams JL, Mann KG (1990) Expression of human bone-related proteins in the hematopoietic microenvironment. J Clin Invest 86:1387–1395
Marcacci M, Kon E, Moukhachev V, Lavroukov A, Kutepov S, Quarto R, Mastrogiacomo M, Cancedda R (2007) Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng 13:947–955
Mödder UI, Khosla S (2008) Skeletal stem/osteoprogenitor cells: current concepts, alternate hypotheses, and relationship to the bone remodeling compartment. J Cell Biochem 103:393–400
Motamed K (1999) SPARC (osteonectin/BM-40). Int J Biochem Cell Biol 31:1363–1366
Mouritzen P, Noerholm M, Nielsen PS (2005) ProbeLibrary: a new method for faster design and execution of quantitative real-time PCR. Nat Methods 4:313–316
Muschler GF, Nakamoto C, Griffith LG (2004) Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 86:1541–1558
Neuhuber B, Swanger SA, Howard L, Mackay A, Fischer I (2008) Effects of plating density and culture time on bone marrow stromal cell characteristics. Exp Hematol 36:1176–1185
Niemeyer P, Krause U, Kasten P, Kreuz PC, Henle P, Südkam NP, Mehlhorn A (2006) Mesenchymal stem cell-based HLA-independent cell therapy for tissue engineering of bone and cartilage. Curr Stem Cell Res Ther 1(1):21–27
Ogata Y (2008) Bone sialoprotein and its transcriptional regulatory mechanism. J Periodontal Res 43:127–135
Tseng SS, Lee MA, Reddi AH (2008) Nonunions and the potential of stem cells in fracture-healing. J Bone Joint Surg Am 90((S1)):92–98
Valtieri M, Sorrentino A (2008) The mesenchymal stromal cell contribution to homeostasis. J Cell Physiol 217(2):296–300
Veyrat-Masson R, Boiret-Dupré N, Rapatel C, Descamps S, Guillouard L, Guérin JJ, Pigeon P, Boisgard S, Chassagne J, Berger MG (2007) Mesenchymal content of fresh bone marrow: a proposed quality control method for cell therapy. Br J Haematol 139(2):312–320
Wälchli C, Koch M, Chiquet M, Odermatt BF, Trueb B (1994) Tissue-specific expression of the fibril-associated collagens XII and XIV. J Cell Sci 107:669–681
Wan C, He Q, McCaigue M, Marsh D, Li G (2006) Nonadherent cell population of human marrow culture is a complementary source of mesenchymal stem cells (MSCs). J Orthop Res 24:21–28
Wiesmann A, Bühring HJ, Mentrup C, Wiesmann HP (2006) Decreased CD90 expression in human mesenchymal stem cells by applying mechanical stimulation. Head Face Med 2:8–13
Wlodarski KH, Galus R, Włodarski P (2004) Non-adherent bone marrow cells are a rich source of cells forming bone in vivo. Folia Biol (Praha) 50(5):167–173
Zhang ZL, Tong J, Lu RN, Scutt AM, Goltzman D, Miao DS (2009) Therapeutic potential of non-adherent BM-derived mesenchymal stem cells in tissue regeneration. Bone Marrow Transplant 43(1):69–81
Acknowledgments
This study was funded by grants from the Italian Ministry of the Health. The Authors thank Nicoletta Zini (Laboratory for cell biology and electron microscopy, Rizzoli Orthopedic Institute, Bologna, Italy) for her help with TEM analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Leonardi, E., Ciapetti, G., Baglìo, S.R. et al. Osteogenic properties of late adherent subpopulations of human bone marrow stromal cells. Histochem Cell Biol 132, 547–557 (2009). https://doi.org/10.1007/s00418-009-0633-x
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1007/s00418-009-0633-x